Frontiers in ImmunologyBioinformaticsPeer-reviewed journal article
Hallucinating structure-conditioned antibody libraries for target-specific binders
Sai Pooja MahajaniD, Jeffrey A. RuffoloiD, Rahel FrickiD, Jeffrey J. GrayiD
Abstract
Antibodies are widely developed and used as therapeutics to treat cancer, infectious disease, and inflammation. During development, initial leads routinely undergo additional engineering to increase their target affinity. Experimental methods for affinity maturation are expensive, laborious, and time-consuming and rarely allow the efficient exploration of the relevant design space. Deep learning (DL) models are transforming the field of protein engineering and design. While several DL-based protein design methods have shown promise, the antibody design problem is distinct, and specialized models for antibody design are desirable. Inspired by hallucination frameworks that leverage accurate structure prediction DL models, we propose the FvHallucinator for designing antibody sequences, especially the CDR loops, conditioned on an antibody structure. Such a strategy generates targeted CDR libraries that retain the conformation of the binder and thereby the mode of binding to the epitope on the antigen. On a benchmark set of 60 antibodies, FvHallucinator generates sequences resembling natural CDRs and recapitulates perplexity of canonical CDR clusters. Furthermore, the FvHallucinator designs amino acid substitutions at the VH-VL interface that are enriched in human antibody repertoires and therapeutic antibodies. We propose a pipeline that screens FvHallucinator designs to obtain a library enriched in binders for an antigen of interest. We apply this pipeline to the CDR H3 of the Trastuzumab-HER2 complex to generate in silico designs improving upon the binding affinity and interfacial properties of the original antibody. Thus, the FvHallucinator pipeline enables generation of inexpensive, diverse, and targeted antibody libraries enriched in binders for antibody affinity maturation.
- organism: human
- assay: protein sequence
- research focus: protein design
- research focus: sequence-to-function modeling
- research focus: drug response / drug discovery
- approach: deep learning
- Citations
- 20
- FWCI
- 2.84
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IgDesign: In vitro validated antibody design against multiple therapeutic antigens using inverse folding
Amir Shanehsazzadeh, Julian Alverio, … Sharrol T. Bachas·bioRxiv·Dec 8, 2023
- Atomically accurate de novo design of antibodies with RFdiffusion
N. R. Bennett, J. L. Watson, … D. Baker·bioRxiv·Mar 14, 2024
- Enhancement of antibody thermostability and affinity by computational design in the absence of antigen
Mark Rowland Hutchinson, Jeffrey A. Ruffolo, … Gilad Kaplan·mAbsPeer-reviewed·Jun 20, 2024
- Antibody Complementarity-Determining Region Sequence Design using AlphaFold2 and Binding Affinity Prediction Model
Takafumi Ueki, Masahito Ohue·Congress in Computer Science, Computer Engineering, and Applied Computing (CSCE)Peer-reviewed·Jul 24, 2023
- Incorporating Pre-training Paradigm for Antibody Sequence-Structure Co-design
Kaiyuan Gao, Lijun Wu, … Tie‐Yan Liu·bioRxiv·Nov 14, 2022
- Antigen-Specific Antibody Design and Optimization with Diffusion-Based Generative Models for Protein Structures
Shitong Luo, Yufeng Su, … Jianzhu Ma·neural information processing systemsPeer-reviewed·Jan 1, 2022